March 2009
Coverage Initiated: BioCurex Inc. (BOCX)
March 17, 2009
For those of you who've been reading the Small Cap Network newsletter for a while, you'll easily remember BioCurex Inc. (OTCBB: BOCX). For those of you who are newer, BioCurex is a company worth getting to know. For both of those groups, today's your chance to acquaint yourself with the company's recent...
For those of you who've been reading the Small Cap Network newsletter for a while, you'll easily remember BioCurex Inc. (OTCBB: BOCX). For those of you who are newer, BioCurex is a company worth getting to know. For both of those groups, today's your chance to acquaint yourself with the company's recent...
December 2007
Small Cap Network - Cleaning House For 2008
December 20, 2007
The end of the year is right around the corner, and I for one am glad. We've been itching to close the books on a handful of our followings, and perhaps benefit from a tax loss (since they didn't benefit us in many other ways). At the same time, there are also a few names we want to be sure to keep...
The end of the year is right around the corner, and I for one am glad. We've been itching to close the books on a handful of our followings, and perhaps benefit from a tax loss (since they didn't benefit us in many other ways). At the same time, there are also a few names we want to be sure to keep...
September 2007
Spicy Pickle Up & Running, Overstock Overbought?
September 25, 2007
Before I forget, I want to remind you about the Spicy Pickle's (OTCBB: SPKL) web video available simply by clicking the nearby image. From the feedback we've gotten so far, the short video has been very helpful for investors, adding any remaining details we couldn't get to in Saturday's profile. Remember...
Before I forget, I want to remind you about the Spicy Pickle's (OTCBB: SPKL) web video available simply by clicking the nearby image. From the feedback we've gotten so far, the short video has been very helpful for investors, adding any remaining details we couldn't get to in Saturday's profile. Remember...
BioCurex's Other Shoe Drops
September 20, 2007
I know I promised all of you a new trading idea on Friday. However, after thinking a little more about it, I've decided to wait until Saturday morning to send it out. I know for a lot of you a 40+ hour workweek can make it tough to read and process one more thing late in the day on a Friday. I'd rather...
I know I promised all of you a new trading idea on Friday. However, after thinking a little more about it, I've decided to wait until Saturday morning to send it out. I know for a lot of you a 40+ hour workweek can make it tough to read and process one more thing late in the day on a Friday. I'd rather...
BioCurex Cancer Test: The Rumor Becomes Real
September 18, 2007
Well, the recent strength from BioCurex (OTCBB: BOCX) shares all makes sense now. This small cap stock flew from 46 cents to 77 cents over the last six weeks - a 67% move - on rising volume. We speculated that they were going to announce some good progress with the next phase of their cancer detection...
Well, the recent strength from BioCurex (OTCBB: BOCX) shares all makes sense now. This small cap stock flew from 46 cents to 77 cents over the last six weeks - a 67% move - on rising volume. We speculated that they were going to announce some good progress with the next phase of their cancer detection...
July 2007
GE Confirms It - Teaming Up With BioCurex
July 02, 2007
There seems to be a common theme recently with some of our profiled stocks....big companies are teaming up with our smaller companies in a 'win/win' scenario. For instance, it was only on Thursday we learned Yahoo! Canada - one of Yahoo! Inc.'s (NASDAQ: YHOO) major regional search sites - was going to...
There seems to be a common theme recently with some of our profiled stocks....big companies are teaming up with our smaller companies in a 'win/win' scenario. For instance, it was only on Thursday we learned Yahoo! Canada - one of Yahoo! Inc.'s (NASDAQ: YHOO) major regional search sites - was going to...
June 2007
BOCX: Tiny Cancer Test Has Huge Potential
June 04, 2007
Sometimes it pays to remember details. Those little things a company just mentions here and there can frequently come back to mean so much more later....and potentially reward those investors who kept track of them. Take today's news from BioCurex Inc. (OTCBB: BOCX) for instance. The company gave us...
Sometimes it pays to remember details. Those little things a company just mentions here and there can frequently come back to mean so much more later....and potentially reward those investors who kept track of them. Take today's news from BioCurex Inc. (OTCBB: BOCX) for instance. The company gave us...
May 2007
BioCurex: Patience Can Pay Off
May 02, 2007
Vindication can be sweet, can't it? That's the first thing I thought after catching the news from BioCurex (OTCBB: BOCX)....seems its shareholders are likely to be well-rewarded soon for being able to be forward-thinking. The company released an update today I feel is a light at the end of the tunnel...
Vindication can be sweet, can't it? That's the first thing I thought after catching the news from BioCurex (OTCBB: BOCX)....seems its shareholders are likely to be well-rewarded soon for being able to be forward-thinking. The company released an update today I feel is a light at the end of the tunnel...
February 2007
BOCX is on the Runway, Fueled by Cancer Test News
February 13, 2007
Do you think there's a market for a cancer screening test that could be performed and interpreted in a matter of minutes? Better yet, what if it could all be done at the doctor's office during a routine visit? Considering there's nothing else that easy and quick in use right now, we'd have to say it...
Do you think there's a market for a cancer screening test that could be performed and interpreted in a matter of minutes? Better yet, what if it could all be done at the doctor's office during a routine visit? Considering there's nothing else that easy and quick in use right now, we'd have to say it...
December 2006
2006 in Review, Plans for 2007
December 27, 2006
Well it's that time of year again - a chance to look back, reflect, and then clean the slate for a new calendar year. We're particularly excited about 2007 because of some major ideas we're already working on for the SmallCap Digest (though you'll have to be patient in the meantime). Yet, we'd be amiss...
Well it's that time of year again - a chance to look back, reflect, and then clean the slate for a new calendar year. We're particularly excited about 2007 because of some major ideas we're already working on for the SmallCap Digest (though you'll have to be patient in the meantime). Yet, we'd be amiss...
This Biotech Buzz Seems To Be Getting Louder
December 07, 2006
As much as we like to come up with our own 'splash' introductions, we don't think there's a more powerful way of describing our opinion of today's focus stock than by using some recent words spoken by the company's CEO..... "We feel that our present valuation is relatively low compared to other firms...
As much as we like to come up with our own 'splash' introductions, we don't think there's a more powerful way of describing our opinion of today's focus stock than by using some recent words spoken by the company's CEO..... "We feel that our present valuation is relatively low compared to other firms...
November 2006
CEO Interview: Detailing a Biotech Opportunity
November 29, 2006
It's been said a company's people - not the company itself - is what generates success. We tend to agree with the sentiment, especially for a smaller company where everyone is intimately involved in the day-to-day operation. That's why we're thrilled we recently got a chance to get up close and personal...
It's been said a company's people - not the company itself - is what generates success. We tend to agree with the sentiment, especially for a smaller company where everyone is intimately involved in the day-to-day operation. That's why we're thrilled we recently got a chance to get up close and personal...
Whatever Happened To....
November 10, 2006
With all the new trading ideas we've been finding for you, we haven't had much of a chance to revisit some of older ones. Well that's going to change today though, as we review some of the names we haven't touched on in a while. We think you may find some renewed opportunity now that the earnings dust...
With all the new trading ideas we've been finding for you, we haven't had much of a chance to revisit some of older ones. Well that's going to change today though, as we review some of the names we haven't touched on in a while. We think you may find some renewed opportunity now that the earnings dust...
October 2006
A Cancer-Test Evolution Expands Its Potential
October 25, 2006
You know how athletes sometimes talk about taking their game to the 'next level'? It's just a succinct way of describing the change from average performance to superior performance (or even from superior to improbable performance). Although you don't hear sports analogies too often in the investing world...
You know how athletes sometimes talk about taking their game to the 'next level'? It's just a succinct way of describing the change from average performance to superior performance (or even from superior to improbable performance). Although you don't hear sports analogies too often in the investing world...
Cancer Test Continues to Show Effectiveness, Accuracy
October 17, 2006
As an investor, would you be interested in hearing more about a company making a prostate cancer detection test that's about twice as accurate as the more common PSA test? Care to know about the only company making a testing kit that can specifically detect gastric/stomach cancer? Would you be glad to...
As an investor, would you be interested in hearing more about a company making a prostate cancer detection test that's about twice as accurate as the more common PSA test? Care to know about the only company making a testing kit that can specifically detect gastric/stomach cancer? Would you be glad to...
August 2006
Sometimes, It's Worth The Wait
August 23, 2006
Good news though - Biocurex was put back into the NASD listing system yesterday evening, and is now trading as bulletin board stock again (with all the right and privileges thereof). Should this really matter? No. Does it really matter? Oh yes - this is a monster-sized victory for the company as well...
Good news though - Biocurex was put back into the NASD listing system yesterday evening, and is now trading as bulletin board stock again (with all the right and privileges thereof). Should this really matter? No. Does it really matter? Oh yes - this is a monster-sized victory for the company as well...
July 2006
BioCurex is Creating a Buzz
July 19, 2006
One of the great pleasures of working for the SmallCap Digest is the opportunity to see great corporate advancements unfold before our very eyes, as small companies start to get bigger for all the right reasons. Of all the leaps and bounds we see, none can be more satisfying – on a professional as well...
One of the great pleasures of working for the SmallCap Digest is the opportunity to see great corporate advancements unfold before our very eyes, as small companies start to get bigger for all the right reasons. Of all the leaps and bounds we see, none can be more satisfying – on a professional as well...
June 2006
Timeless Lessons
June 23, 2006
Lately we've been focusing on our watchlist stocks with major news to discuss, but with nothing hard-hitting to look at today, we'll devote some attention to a couple of names we haven't looked at recently. This includes a detailed look at charts. Along the way, we're going to use our real-life examples...
Lately we've been focusing on our watchlist stocks with major news to discuss, but with nothing hard-hitting to look at today, we'll devote some attention to a couple of names we haven't looked at recently. This includes a detailed look at charts. Along the way, we're going to use our real-life examples...
May 2006
Early Cancer Detection - Good for the Portfolio
May 16, 2006
Early Detection of the Stock We started following BioCurex (BOCX.PK) back in October of '03 at a mere $.17 cents when Celgene (NASDAQ: CELG) and Genentech (NASDAQ: DNA), two of the most prolific names in biotech today, were hovering around $10 and $40 respectively. Although all three of these biotechs...
Early Detection of the Stock We started following BioCurex (BOCX.PK) back in October of '03 at a mere $.17 cents when Celgene (NASDAQ: CELG) and Genentech (NASDAQ: DNA), two of the most prolific names in biotech today, were hovering around $10 and $40 respectively. Although all three of these biotechs...
April 2006
Be Amazed. Again.
April 27, 2006
On the heels of biotech BioCurex's (BOCX.PK) recent impressive announcement of its RECAF blood test results with regard to the detection of early stage (I and II) breast cancer(review our April 11th article for background) the Company released (release below) more details of the test as well as information...
On the heels of biotech BioCurex's (BOCX.PK) recent impressive announcement of its RECAF blood test results with regard to the detection of early stage (I and II) breast cancer(review our April 11th article for background) the Company released (release below) more details of the test as well as information...
Cancer Detection: Prepare to Be Amazed
April 11, 2006
Biotech BioCurex (PK: BOCX) announced Tuesday, (release below) remarkable results from a recent blind study; the Company's proprietary RECAF blood test was able to detect breast cancer at the very earliest and therefore most curable of stages --with what we believe to be an unprecedented degree of accuracy...
Biotech BioCurex (PK: BOCX) announced Tuesday, (release below) remarkable results from a recent blind study; the Company's proprietary RECAF blood test was able to detect breast cancer at the very earliest and therefore most curable of stages --with what we believe to be an unprecedented degree of accuracy...
December 2005
Feature: 2005 in Review - Beauties and the Beasts.
December 21, 2005
Feature: 2005 in Review - Beauties and the Beasts. I’m not going to belabor the fact that the Santa rally hasn’t materialized for the smallcaps this year. As a matter of fact, the fall pretty much sucked out loud for the genre. Along with some good wins, along with everyone else, we also took some lumps...
Feature: 2005 in Review - Beauties and the Beasts. I’m not going to belabor the fact that the Santa rally hasn’t materialized for the smallcaps this year. As a matter of fact, the fall pretty much sucked out loud for the genre. Along with some good wins, along with everyone else, we also took some lumps...
October 2005
Feature: Biocurex - Is the Best Yet to Come?
October 06, 2005
Feature: BioCurex - Is the Best Yet to Come? Long-term readers will know that we have been covering biotech BioCurex (BOCX.PK) for exactly two years. And it’s been anything but dull. We’ve stuck with it because, in our opinion, the company stands to make a profound difference in the way cancer is diagnosed...
Feature: BioCurex - Is the Best Yet to Come? Long-term readers will know that we have been covering biotech BioCurex (BOCX.PK) for exactly two years. And it’s been anything but dull. We’ve stuck with it because, in our opinion, the company stands to make a profound difference in the way cancer is diagnosed...
September 2005
Feature: Biocurex Steps Up to New Level
September 23, 2005
Feature: Biocurex Steps Up to New Level BioCurex (BOCX.PK) steps up to new level. BioCurex, one of the Small Cap Digest’s stalwart wins, was out with a very significant news announcement pre-open today (release below). For members of the SmallCap Digest, BOCX has been Mr. Toad’s wild profit ride. Consider...
Feature: Biocurex Steps Up to New Level BioCurex (BOCX.PK) steps up to new level. BioCurex, one of the Small Cap Digest’s stalwart wins, was out with a very significant news announcement pre-open today (release below). For members of the SmallCap Digest, BOCX has been Mr. Toad’s wild profit ride. Consider...
July 2005
Feature: Biocurex - The Word is Out.
July 23, 2005
Feature: BioCurex - The Word is Out. SmallCap Digest is pleased to make available --to current as well as new subscribers-- an extremely detailed 24-page research report on the current and future prospects for one of our favorite biotech companies, BioCurex Inc (BOCX.PK). To acquire your online copy...
Feature: BioCurex - The Word is Out. SmallCap Digest is pleased to make available --to current as well as new subscribers-- an extremely detailed 24-page research report on the current and future prospects for one of our favorite biotech companies, BioCurex Inc (BOCX.PK). To acquire your online copy...
Emergent Growth Analytics Research Report - Biocurex
July 20, 2005
<SCRIPT LANGUAGE="JavaScript" SRC="/javascript/popup_window.js"></SCRIPT>Recaf (TM) Platform Technology Poised for Significant Growth in Cancer Diagnostics and Therapeutics Markets. The SmallCap Network and SmallCap Digest Newsletter are owned by TGR Group, LLC. We encourage all readers to please read our disclaimer regarding Biocurex by <A HREF="javascript:newWindow('http://www.smallcapnetwork.com/profile_disclosure/#BOCX', 'newin', false, false, false, true, false, true, true, false, '800', '600');">Clicking Here</A>.
<SCRIPT LANGUAGE="JavaScript" SRC="/javascript/popup_window.js"></SCRIPT>Recaf (TM) Platform Technology Poised for Significant Growth in Cancer Diagnostics and Therapeutics Markets. The SmallCap Network and SmallCap Digest Newsletter are owned by TGR Group, LLC. We encourage all readers to please read our disclaimer regarding Biocurex by <A HREF="javascript:newWindow('http://www.smallcapnetwork.com/profile_disclosure/#BOCX', 'newin', false, false, false, true, false, true, true, false, '800', '600');">Clicking Here</A>.
Feature: BioCurex Awakens. Tracking Eden's Volatility.
July 13, 2005
Feature: BioCurex Awakens. Tracking Eden’s Volatility. Eden Energy (OTCBB: EDNE) shares have, to say the least, had an active few days. After running up to $4.59 on Monday from under $3 last week, the shares pulled back to just under $4 Tuesday and closed the day at $4.24. Whether the rise is a result...
Feature: BioCurex Awakens. Tracking Eden’s Volatility. Eden Energy (OTCBB: EDNE) shares have, to say the least, had an active few days. After running up to $4.59 on Monday from under $3 last week, the shares pulled back to just under $4 Tuesday and closed the day at $4.24. Whether the rise is a result...
June 2005
Feature: Once Around the Stable - Biophan, Biocurex et al...
June 22, 2005
Feature: Once Around the Stable - Biophan, BioCurex et al… Received some great emails on our educational/big cap strategy pieces over the last week. We like to mix it up a bit so if you have any market topics you’d like to see us cover—no matter how basic you may think they are-- send ‘em in here. Or...
Feature: Once Around the Stable - Biophan, BioCurex et al… Received some great emails on our educational/big cap strategy pieces over the last week. We like to mix it up a bit so if you have any market topics you’d like to see us cover—no matter how basic you may think they are-- send ‘em in here. Or...
Feature: Biotech - The Next Big Boom?
June 14, 2005
Feature: Biotech - The Next Big Boom? For the most part, Biotech companies don’t trade on fundamentals. They are trade on the three ‘P’s”: potential, pipeline and vision. OK, two p’s and a v. Even senior companies’ prices--such as Genentech (NYSE: DNA) --look positively goofy if you try to rationalize...
Feature: Biotech - The Next Big Boom? For the most part, Biotech companies don’t trade on fundamentals. They are trade on the three ‘P’s”: potential, pipeline and vision. OK, two p’s and a v. Even senior companies’ prices--such as Genentech (NYSE: DNA) --look positively goofy if you try to rationalize...
Feature: Biocurex's RECAF Marker - The World is Waiting.
June 03, 2005
Feature: BioCurex’s RECAF Marker - The World is Waiting. For several days in September, in Rhodes Greece, the elite of the oncology community—academia and industry—will gather at the 33rd congress of the International Society of Oncodevelopmental Biology and Medicine (ISOBM). This prestigious event...
Feature: BioCurex’s RECAF Marker - The World is Waiting. For several days in September, in Rhodes Greece, the elite of the oncology community—academia and industry—will gather at the 33rd congress of the International Society of Oncodevelopmental Biology and Medicine (ISOBM). This prestigious event...
May 2005
Feature: Biocurex Expands RECAF Technologies.
May 20, 2005
Feature: BioCurex Expands RECAF Technologies. As we noted in our May 11th article, BioCurex (BOCK.PK) is expanding its cancer imaging and therapy technology focus. With the announcement (release below) of a collaboration with the Goshen, Indiana-based Center for Cancer Care, the Company already appears...
Feature: BioCurex Expands RECAF Technologies. As we noted in our May 11th article, BioCurex (BOCK.PK) is expanding its cancer imaging and therapy technology focus. With the announcement (release below) of a collaboration with the Goshen, Indiana-based Center for Cancer Care, the Company already appears...
Feature: Biocurex - The Year Ahead: Hunter, Killer.
May 11, 2005
Feature: BioCurex - The Year Ahead: Hunter, Killer. When we first brought BioCurex (BOCX.PK) to the readership at 17 cents in October of 2003, it was an interesting little biotech with the promise of technologies that we felt could revolutionize the early detection of cancer. And for those who have...
Feature: BioCurex - The Year Ahead: Hunter, Killer. When we first brought BioCurex (BOCX.PK) to the readership at 17 cents in October of 2003, it was an interesting little biotech with the promise of technologies that we felt could revolutionize the early detection of cancer. And for those who have...
April 2005
Feature: Biocurex - Blood Test Detects More Cancers. MarketNotes.
April 15, 2005
Feature: Biocurex - Blood Test Detects More Cancers. MarketNotes. Until a cure for cancer is found, early detection of this disease remains paramount. Biocurex (BOCX.PK) announced today (release below) that it had found that its RECAF blood test detected 92 percent of cervical cancers using only a drop...
Feature: Biocurex - Blood Test Detects More Cancers. MarketNotes. Until a cure for cancer is found, early detection of this disease remains paramount. Biocurex (BOCX.PK) announced today (release below) that it had found that its RECAF blood test detected 92 percent of cervical cancers using only a drop...
March 2005
Feature: Biocurex - MGMT Discusses Licensing Deal.
March 31, 2005
Feature: Biocurex - MGMT Discusses Licensing Deal. After impressive news (read our previous piece for the details) from biotech Biocurex (BOCX.PK) on Tuesday announcing an outstanding licensing agreement with Abbott Labs (NYSE: ABT) BOCX’s share price experienced significant volatility. The company...
Feature: Biocurex - MGMT Discusses Licensing Deal. After impressive news (read our previous piece for the details) from biotech Biocurex (BOCX.PK) on Tuesday announcing an outstanding licensing agreement with Abbott Labs (NYSE: ABT) BOCX’s share price experienced significant volatility. The company...
Feature: Biocurex Signs Abbott Labs - Licensing Deal Done.
March 29, 2005
Feature: Biocurex Signs Abbott Labs - Licensing Deal Done. Patience rewarded. Significant milestone achieved. Those two phrases encapsulate the importance of the joint announcement made today (release below) by biotech Biocurex (BOCX.PK) of the completion of a deal granting world-wide, semi-exclusive...
Feature: Biocurex Signs Abbott Labs - Licensing Deal Done. Patience rewarded. Significant milestone achieved. Those two phrases encapsulate the importance of the joint announcement made today (release below) by biotech Biocurex (BOCX.PK) of the completion of a deal granting world-wide, semi-exclusive...
Feature: Biocurex Rising. Company Updates.
March 01, 2005
Feature: Biocurex Rising. Company Updates. As we noted on the SCBLOG over the weekend, there appears to be something going on with the shares of Biocurex (BOCX.PK). Friday, the shares closed at $1.15, after closing at 76 cents, Thursday. Friday’s volume was north of 800,000 shares. On Monday the shares...
Feature: Biocurex Rising. Company Updates. As we noted on the SCBLOG over the weekend, there appears to be something going on with the shares of Biocurex (BOCX.PK). Friday, the shares closed at $1.15, after closing at 76 cents, Thursday. Friday’s volume was north of 800,000 shares. On Monday the shares...
December 2004
Feature: Year of the SmallCap Digest.
December 28, 2004
Feature: Year of the SmallCap Digest. 2004 was a great year for SmallCap Digest. Over approximately 150 articles, we complimented our picks and Trading Alerts with pithy educational pieces on options strategies, the mechanics of SEC filings, and a whole raft of other topics of interest—some suggested...
Feature: Year of the SmallCap Digest. 2004 was a great year for SmallCap Digest. Over approximately 150 articles, we complimented our picks and Trading Alerts with pithy educational pieces on options strategies, the mechanics of SEC filings, and a whole raft of other topics of interest—some suggested...
November 2004
Feature: Biocurex - Prostate Cancer Results Trump PSA Test.
November 30, 2004
Feature: BioCurex - Prostate Cancer Results Trump PSA Test. BioCurex (BOCX.PK) has added prostate results to its list of cancers detected by its RECAF™ blood test. Along with the previous detection results for stomach, lung, ovarian, breast and colon, the company has added significant findings for the...
Feature: BioCurex - Prostate Cancer Results Trump PSA Test. BioCurex (BOCX.PK) has added prostate results to its list of cancers detected by its RECAF™ blood test. Along with the previous detection results for stomach, lung, ovarian, breast and colon, the company has added significant findings for the...
October 2004
Feature: Spectrum Rises. Biocurex Idles. And, of Course Isonics.
October 18, 2004
Feature: Spectrum Rises. Biocurex Idles. And, of Course Isonics. There are subtle signs that the SmallCap market is improving. Momentum is returning, volumes are rising and more and more, price dips are being met with renewed buying. As we’ve mentioned previously, we believed that the fall looked constructive...
Feature: Spectrum Rises. Biocurex Idles. And, of Course Isonics. There are subtle signs that the SmallCap market is improving. Momentum is returning, volumes are rising and more and more, price dips are being met with renewed buying. As we’ve mentioned previously, we believed that the fall looked constructive...
September 2004
Feature: Biocurex - Cancer Detection List Grows, Again.
September 09, 2004
Feature: Biocurex - Cancer detection list grows, again. Short of a cure, early cancer detection is arguably the holy grail of medical diagnostics. To best understand the relevance of Biocurex’s (BOCX.PK) cancer detection technology, investors need to grasp the concept of specificity and sensitivity...
Feature: Biocurex - Cancer detection list grows, again. Short of a cure, early cancer detection is arguably the holy grail of medical diagnostics. To best understand the relevance of Biocurex’s (BOCX.PK) cancer detection technology, investors need to grasp the concept of specificity and sensitivity...
July 2004
Feature: Does Bill Gates Read SmallCap? Biocurex Battles Back.
July 22, 2004
Feature: Does Bill Gates read SmallCap? Biocurex battles back. In our last piece, we stated that Microsoft (NASDAQ: MSFT) was likely close to spending its $60 billion cash mountain for the benefit of shareholders. Within 90 minutes of that article’s posting, Tuesday, at our website (www.smallcapdigest.net...
Feature: Does Bill Gates read SmallCap? Biocurex battles back. In our last piece, we stated that Microsoft (NASDAQ: MSFT) was likely close to spending its $60 billion cash mountain for the benefit of shareholders. Within 90 minutes of that article’s posting, Tuesday, at our website (www.smallcapdigest.net...
Feature: Biocurex Exposes Itself and Turns the Corner.
July 14, 2004
Feature: BioCurex exposes itself and turns the corner. There’s no argument that the combination of crappy markets and corporate challenges have roiled the share price of cancer detection concern BioCurex (BOCX.PK). Now, with its corporate filings up to date, a successful road trip completed to expose...
Feature: BioCurex exposes itself and turns the corner. There’s no argument that the combination of crappy markets and corporate challenges have roiled the share price of cancer detection concern BioCurex (BOCX.PK). Now, with its corporate filings up to date, a successful road trip completed to expose...
June 2004
Feature: Biocurex - For Better or Worse...
June 09, 2004
Feature: BioCurex - For better or worse… Of all the stocks we follow, none has been more active than biomedical device concern BioCurex (BOCX.PK). The action in its shares can be viewed as representative of both the best and worst of trading in the SmallCap market. Although it has had its challenges—as...
Feature: BioCurex - For better or worse… Of all the stocks we follow, none has been more active than biomedical device concern BioCurex (BOCX.PK). The action in its shares can be viewed as representative of both the best and worst of trading in the SmallCap market. Although it has had its challenges—as...
May 2004
Feature: BioCurex - How's this for Abstracts?
May 18, 2004
Feature: BioCurex - How’s this for Abstracts? BioCurex (BOCX.PK) announced Monday that the ISOBM (The International Society of Oncodevelopmental Biology and Medicine) has reviewed and accepted five abstracts regarding the company’s Histo-and Serum-Recaf™ diagnostic technologies for presentation at the...
Feature: BioCurex - How’s this for Abstracts? BioCurex (BOCX.PK) announced Monday that the ISOBM (The International Society of Oncodevelopmental Biology and Medicine) has reviewed and accepted five abstracts regarding the company’s Histo-and Serum-Recaf™ diagnostic technologies for presentation at the...
Feature: Biocurex - Japan Test Results, Impressive.
May 04, 2004
Feature: BioCurex - Japan test results, Impressive. Tuesday morning, BioCurex (BOCX.PK) released data (release shown below) from an independent evaluation of its Histo-RECAF™ tissue biopsy cancer detection system. The independent study was conducted in Japan by Dr. Kazuhita Taketa, MD, Head of the Clinical...
Feature: BioCurex - Japan test results, Impressive. Tuesday morning, BioCurex (BOCX.PK) released data (release shown below) from an independent evaluation of its Histo-RECAF™ tissue biopsy cancer detection system. The independent study was conducted in Japan by Dr. Kazuhita Taketa, MD, Head of the Clinical...
Feature: Biocurex Update
May 01, 2004
Feature: BioCurex Update Never in over 20 years of market watching have I ever seen anything like the recent activity in the shares of biotech BioCurex. (BOCX.PK). SmallCap Digest wants to bring you the latest we have on the company, a recap and our understanding as to the future timeline of events...
Feature: BioCurex Update Never in over 20 years of market watching have I ever seen anything like the recent activity in the shares of biotech BioCurex. (BOCX.PK). SmallCap Digest wants to bring you the latest we have on the company, a recap and our understanding as to the future timeline of events...
April 2004
Feature: Biocurex - Too Fast and Too Furious?
April 09, 2004
Feature: BioCurex - Too fast and Too furious? The shares of BioCurex Inc (OTCBB: BOCX) have recently been on a tear. Trading in the stock idled at a sleepy 20 cents a share just two weeks ago. Inexplicably, the stock charged up to 50 cents in two trading days, and then went on a wild run which saw an...
Feature: BioCurex - Too fast and Too furious? The shares of BioCurex Inc (OTCBB: BOCX) have recently been on a tear. Trading in the stock idled at a sleepy 20 cents a share just two weeks ago. Inexplicably, the stock charged up to 50 cents in two trading days, and then went on a wild run which saw an...
Feature: Biocurex - Firing On ALL Cylinders.
April 05, 2004
Feature: BioCurex - Firing on ALL cylinders. As dawn broke, Monday, BioCurex (OTCBB: BOCX) stormed out of the gate, trading north of $1.40 a share. The shares closed at 54 cents, Friday. In our original Trading Alert late last year, we brought the shares to the SmallCap readership at 17 cents. That’s...
Feature: BioCurex - Firing on ALL cylinders. As dawn broke, Monday, BioCurex (OTCBB: BOCX) stormed out of the gate, trading north of $1.40 a share. The shares closed at 54 cents, Friday. In our original Trading Alert late last year, we brought the shares to the SmallCap readership at 17 cents. That’s...
November 2003
Biocurex Adds China. Opportunities in C-CHIP.
November 12, 2003
BioCurex adds China. Opportunities in C-CHIP. We brought you a Trading Alert on BioCurex (OTC:BB BOCX) three weeks ago when the stock was trading at 17 cents. Currently, the shares are trading at around 30 cents--pretty close to a standup double. Nevertheless, we believe that there is much more upside...
BioCurex adds China. Opportunities in C-CHIP. We brought you a Trading Alert on BioCurex (OTC:BB BOCX) three weeks ago when the stock was trading at 17 cents. Currently, the shares are trading at around 30 cents--pretty close to a standup double. Nevertheless, we believe that there is much more upside...
October 2003
Biocurex: Unparalleled Cancer Detection, Assure Energy Update and Preferred Member Opportunity
October 31, 2003
BioCurex: Unparalleled Cancer Detection, Assure Energy Update and Preferred Member Opportunity Cancer markers are molecules that distinguish cancerous cells from normal cells. Never has there been a universal marker identified that appears in all types of cancer thereby enabling early detection. Hence...
BioCurex: Unparalleled Cancer Detection, Assure Energy Update and Preferred Member Opportunity Cancer markers are molecules that distinguish cancerous cells from normal cells. Never has there been a universal marker identified that appears in all types of cancer thereby enabling early detection. Hence...
Trading Alert: Biocurex Inc. - Lightning CAN Strike Twice
October 23, 2003
Trading Alert: BioCurex Inc. - Lightning CAN Strike Twice On November 7th, 2002, SmallCap Digest initiated coverage on a small, Virginia-based biotech named CEL-SCI (AMEX: CVM) which has developed some amazing --and potentially life-saving-- immunotherapies for the treatment of cancer and viral disease...
Trading Alert: BioCurex Inc. - Lightning CAN Strike Twice On November 7th, 2002, SmallCap Digest initiated coverage on a small, Virginia-based biotech named CEL-SCI (AMEX: CVM) which has developed some amazing --and potentially life-saving-- immunotherapies for the treatment of cancer and viral disease...
